Codexis Inc reports results for the quarter ended in September 30 - Earnings Summary

Codexis

01/11/2024 03:33

* Codexis Inc  CDXS.OQ  reported a quarterly adjusted loss
of 29
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -50 cents.  The mean expectation of eight analysts for the
quarter was for a loss of 24 cents per share. Wall Street
expected results to range from -26 cents to -19 cents per share.
    * Revenue rose 38.3% to $12.83 million from a year ago;
analysts
expected $11.48 million. 
    * Codexis Inc's reported EPS for the quarter was a loss
of 29
cents​.
    * The company reported a quarterly loss of $20.64 million.
    * Codexis Inc shares had risen by 4.2% this quarter and
gained 5.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 29.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Codexis Inc is
$5.00 
This summary was machine generated from LSEG data November 1 at
03:32 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.24          -0.29          Missed
 Jun. 30 2024      -0.26          -0.32          Missed
 Mar. 31 2024      -0.18          -0.16          Beat
 Dec. 31 2023      -0.12          -0.10          Beat